Surfactant therapy helps newborns, especially preemies, breathe better. It stabilizes lung function and supports babies with respiratory distress syndrome, improving their chances of healthy development.
Surfactant is a natural fluid in the lungs that keeps air sacs open, preventing collapse. It’s essential for easy breathing, especially in newborns with underdeveloped lungs.
Premature babies often lack sufficient surfactant, making it hard to breathe. Surfactant therapy provides essential lung support, helping them breathe and reducing health risks.
Surfactant is administered through a breathing tube directly into the baby’s lungs, allowing them to inflate fully and improving comfort by easing breathing effort.
There are synthetic and natural surfactants used in therapy. Both options are effective, providing needed respiratory support for neonates at risk of breathing issues.
Surfactant therapy reduces lung injury, improves oxygen levels, and stabilizes breathing. This therapy promotes healthier lung development in preterm infants.
Babies receiving surfactant therapy are monitored closely in NICUs. Monitoring helps ensure positive response to treatment and supports breathing progress and overall recovery.
Surfactant therapy has improved survival rates and respiratory outcomes in preterm infants. It’s an important advancement, giving premature babies a healthier start.
9455794557
Surfactant therapy is vital for supporting premature babies’ breathing. By stabilizing lung function, it has transformed neonatal care, improving health outcomes for newborns.